«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:

第5卷

期数:

2012年12期

页码:

951-0

栏目:

综述

出版日期:

2012-12-06

文章信息/Info

Title:

Progress of research methods on active ingredient group of Chinese herbal formula

作者:

宋芳娇; 曾克武; 王学美;

Author(s):

SONG Fang-jiao;  ZENG Ke-wu;  WANG Xue-mei.

Laboratory of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing 100034, China

关键词:

中药复方;  有效成分组;  药物活性评价;  高通量药物筛选

Keywords:

Chinese herbal formula;  Active ingredient group;  Drug activity evaluation;  High-throughput drug screening

分类号:

R917

DOI:

-

文献标志码:

A

摘要:

中药复方是中医学中的宝贵财富,多成分、多靶点是其优势和特色所在。但由于中药复方成分复杂,作用机理不清,量-效关系缺乏科学的数据支持,严重阻碍了中医药的现代化和国际化进程。中药复方有效成分组是指中药复方中与该复方临床治疗目的密切相关的所有药理活性成分。随着有效成分组概念的提出,中药复方的有效成分组研究日益受到人们的关注。本文对中药复方有效成分组的基本原理和近几年开展的相关研究方法进行了综述,主要介绍了化合物群分析法,指纹图谱分析,药代动力学,高通量药物筛选等技术在中药复方有效成分组研究中的应用,这不仅有助于推动民族药物的继承和发展,为新药开发提供思路和技术上的参考,同时也有助于促进中医药现代化并最终走向世界。

Abstract:

Chinese herbal formula is valuable property of traditional Chinese medicine, multi-component and multi-target are the advantages and features. However, due to the complex ingredients of Chinese herbal formula, mechanism of action is unclear and the dose-effect relationships lack the scientific data to support, all these seriously hampers the process of modernization and internationalization of traditional Chinese medicine. Active ingredient group of Chinese herbal formula means all the pharmacologically active ingredient closely related to the clinical therapeutic purposes. With the concept of the active ingredient group of traditional Chinese medicine proposed, this field has become an increasing concern. The article reviewed the basic principles and research in recent years, mainly introducing the application of the compound group analysis, fingerprint analysis,drug metabolism and pharmacokinetics and high-throughput screening technology in the study of active ingredient group. This not only helps to provide ideas and technical reference for the development of new drugs by promoting the inheritance and development of the national drug,while also contribute to the modernization of Chinese medicine and process to the world.

参考文献/References:

[1] 杜冠华.中药复方有效成分组学研究[J].中成药,2002,24(11):878-880.
[2] 张家玮,孙建宁,张爱林.有效成分组―中药复方活性物质基础研究方法刍议[J].中国中医药信息杂志,2006,13(2):4-5.
[3] 刘斌,石任兵.苦参汤中生物碱部位的化学成分[J].中国中药杂志,2006,31(7):557-560.
[4] 刘明生,郭小明,张俊清,等.复方肠胃康中黄酮类成分的研究[J].世界科学技术-中医药现代化,2010,12(5):811-813.
[5] 朱精英,魏丽萍,吴春敏.中药指纹图谱的研究进展[J].海峡药学,2011,23(4):5-8.
[6] 郭秋平,高英,李卫民.中药百合 HPLC 指纹图谱研究[J].中成药,2011,33(8):1280-1285.
[7] 陈永刚,林励.柑橘属常用中药黄酮类成分 HPLC 指纹图谱研究与比较[J].中国中药杂志,2011,36(19):2660-2665.
[8] 曲静伟,董文雅,洪中立,等.地高辛的血清浓度监测和剂量探讨[J].现代实用医学,2005,17(9):560-562.
[9] 潘嘉,王家葵,邹文俊,等.抑菌效应法测定川芎挥发油药动学参数[J].中药药理与临床,2002,18(4):18-19.
[10] 王学美.五子衍宗液延衰缓老的临床研究[J].中国中西医结合杂志,1992,12(1):23-25.
[11] 王学美,富宏,刘庚信,等.加味五子衍宗颗粒治疗轻度认知障碍的研究[J].中国中西医结合杂志,2004,24(5):392-395.
[12] 廖子君,宋永春,陈晓泉.大黄素对人肺腺癌A-549细胞增殖周期影响的实验研究[J].中华肿瘤防治杂志2007,14(5):342-344.
[13] 肖凤霞,周莉玲,李锐.药物累积法测定四逆汤制剂的药动学参数[J].时珍国医国药,2006,17(2):228-229.
[14] 王宁宁,李月,姜明燕.血清药理学方法研究复方中药对癫痫大鼠离体脑片的作用[J].中药材,2008,31(4):573-575.
[15] 王文萍,姜良铎.中药肠安泰体外对Co26l u大肠癌细胞的血清药理学研究[J].中华中医药杂志,2006,21(4):213-215.
[16] 曾克武,王学美,富宏,等.加味五子衍宗方含药脑脊液对β淀粉样蛋白诱导海马神经元损伤的保护作用[J].中国中西医结合杂志,2010,30(8):851-856.
[17] 陈艳艳,才丽平,王浩,等.芳香开窍类中药含药脑脊液对星形胶质细胞水通道-4表达的影响[J].现代中西医结合杂志,2008,17(12):1783-1786.
[18] 何祥久,邱峰,姚新生.中药复方研究现状和思路[J].化学进展,2001,13(6):481-485.
[19] 李忠红,倪坤仪.中药复方有效成分研究进展[J].中成药,2006,28(1):114-117.
[20] 王月华,张海霞,李奇,等.小续命汤有效成分组的高通量筛选研究[J].中西医结合学报,2006,4(1):64-67.
[21] 张冉,刘泉,申竹芳,等.应用α-葡萄糖苷酶抑制剂高通量筛选模型筛选降血糖中药[J].中国药学杂志,2007,42(10):740-742.
[22] 孔焕宇,杨丽平,陈玉武,等.复方中药银黄口服液有效成分膜分离工艺及正交实验研究[J].中国实验方剂学杂志,2006,12(3):1-2.
[23] He JX,Tadoto Tani.Reduction of bioavailability of glycyrrhizin in Shaoyao_Gancao_Tang by co_administered antibacterial drugs and ways of minimizing it( Part I)Alterat ion of bioavai labi l ity of glycyrrhizin from repeated administration of Shaoyao_Gancao_Tang[J]. Tianjin Journal of Traditional Chinese Medicine,2004,21(4):343-345.
[24] 刘小美,舒适,宋丽娜,等.2型糖尿病大鼠胰岛素受体底物-2基因表达变化及中药的干预作用[J].辽宁中医杂志,2009,36(9):1600-1602.
[25] Bi XD, Zhao J,Wang W,et al.Effects of Antai Yangxue mixture on cell apoptosis and Fas/FasL mRNA expression in rats with transplanted kidney[J]. Journal of Clinical Rehabilitative Tissue Engineering Research,2009,13(44):8792-8796.
[26] 钱会南,宫淑敏,杨舒,等.脾虚大鼠脑内IL-18蛋白及基因表达变化和益气扶正中药的干预研究[J].北京中医药大学学报,2010,33(7):472-475.

相似文献/References:

[1]郭宇,魏玮,杨俭勤.代谢组学在病证相关中药复方研究中的应用[J].环球中医药,2015,8(11):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]
　GUO Yu,WEI Wei,YANG Jian qin..Application of metabonomics in the study of disease integrating with syndrome and Chinese compound medicine[J].,2015,8(12):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]
[2]郭宇,魏玮,杨俭勤.代谢组学在病证相关中药复方研究中的应用[J].环球中医药,2015,8(11):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]
　GUO Yu,WEI Wei,YANG Jian qin..Application of metabonomics in the study of disease integrating with syndrome and Chinese compound medicine[J].,2015,8(12):1416.[doi:10.3969/j.issn.1674-1749.2015.11.042]
[3]陈会 李新民 路岩莉 孙丹 聂坤 房艳艳 任艳艳.中药复方熄风胶囊对难治性癫痫大鼠多药耐药基因MDR1mRNA表达的影响[J].环球中医药,2017,10(07):692.[doi:10.3969/j.issn.1674-1749.2017.07.004]
　CHEN Hui,LI Xinmin,LU Yanli,et al.Effect of the Chinese herbal compound Xifeng capsule on expression of MDR1mRNA of intractable epilepsy rats[J].,2017,10(12):692.[doi:10.3969/j.issn.1674-1749.2017.07.004]
[4]董孟佳,许尤琪,方祯.中药复方治疗肝癌机理的实验研究进展[J].环球中医药,2017,10(10):1170.[doi:10.3969/j.issn.1674-1749.2017.10.036]
　DONG Mengjia,XU Youqi,FANG Zhen..Experimental research progress on the mechanism of Chinese herbal compound in treatment of liver cancer[J].,2017,10(12):1170.[doi:10.3969/j.issn.1674-1749.2017.10.036]

备注/Memo

备注/Memo:

基金项目:国家自然科学基金面上项目(30973813,81173369)
作者单位：100034,北京大学第一医院中西医结合研究室[宋芳娇(硕士研究生)、曾克武、王学美]
作者简介：宋芳娇(1987- ),女,2011级在读硕士研究生。研究方向:中西医结合老年病。E-mail:songfangjiao@163.com
通讯作者：王学美(1964- ),女,博士,教授,研究员,博士生导师。研究方向:中西医结合老年病。E-mail:wangxuemeibjmu@163.com

常用功能

更新日期/Last Update: 1900-01-01